Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology France, Germany, Italy, Japan, Spain, USA, United Kingdom Healthcare Optimization and Patient Equity for Lung Cancer in China (“HOPE”)Release Date:Partner: The International Association for the Study of Lung Cancer (IASLC)Quality Improvement Oncology China Optimizing ER+ Metastatic Breast Cancer Treatment: incorporating emerging treatment options and biomarker testingEducation Oncology All Optimizing vaccination pathways among at-risk or immunocompromised adults and the elderly in ItalyRelease Date:Quality Improvement Vaccines Italy Expanding Access to Maternal Immunization Resources and Point-of-Care ToolsRelease Date:Education Vaccines USA Optimizing ATTR-CM Diagnosis and Care in Heart Failure Patients Quality Improvement Grant Program Request for ProposalsRelease Date:Partner: American College of CardiologyQuality Improvement Rare Disease USA Optimizing maternal immunization practice in Saudi ArabiaRelease Date:Quality Improvement Vaccines Saudi Arabia Role of Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology All Projects of Equalization of Cancer InformationRelease Date:Partner: Japanese Society of Clinical OncologyQuality Improvement Oncology Japan Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for ChildrenRelease Date:Quality Improvement Vaccines Japan Efforts to Improve Quality of Migraine Medical CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Title Grant Type Focus Area Country Application Due Date Quality Improvement initiatives optimizing AF and VTE management in CanadaRelease Date:Review Process:Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets)Release Date:Review Process:Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including DialysRelease Date:Education Hospital Albania Integrated Approach to Breast Health EquityRelease Date:Review Process:Patient Registries In Metastatic Breast CancerRelease Date:Review Process:Improving Patient Care in Tobacco DependencyRelease Date:Review Process:Antimicrobial Stewardship in the Latin America RegionRelease Date:Review Process:Management of Atopic Dermatitis – International Developed MarketsRelease Date:Review Process:Improving Standard of Care for Chronic ADRelease Date:Review Process:NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer CareRelease Date:Review Process:Translating the Atopic Dermatitis (AD)Release Date:Review Process:UK Oncology Quality Improvement GrantsRelease Date:Review Process: